Malaria antigen

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5231168
SERIAL NO

07409658

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a polypeptide comprising a characteristic amino acid sequence derived from the Plasmodium falciparum antigen GLURP, a polypeptide which is recognized by an antibody raised against or reactive with a polypeptide comprising said characteristic amino acid sequence and/or an antibody reactive with native GLURP, a nucleic acid molecule (DNA-fragment) encoding said polypeptide, an expression vector carrying the nucleic acid molecule, an organism expressing said nucleic acid molecule so as to produce said polypeptide, a monoclonal antibody directed against said polypeptide, a diagnostic agent comprising said antibody or said polypeptide for use in assaying Plasmodium falciparum infection and thus diagnosing malaria, and the use of said antibody or said polypeptide for therapeutic purposes, e.g. as a component in a vaccine.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • STATENS SERUM INSTITUT

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Borre, Martin Copenhagen, DK 2 53
Dziegiel, Morten Roskilde, DK 1 42
Jakobsen, Palle H Koge, DK 1 42
Jepsen, Soren Overisse, BE 2 43
Rieneck, Klaus Copenhagen, DK 1 42
Vuust, Jens Dragor, DK 1 42
Wind, Annette Farum, DK 1 42

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation